Artelo Biosciences, Inc. (OTCPK:ARTL) announced that it has entered into subscription agreement for a private placement of 796,779 units at $0.65 per unit for gross proceeds of $517,916 with 19 accredited individuals investors on January 26, 2018. Each unit will comprise of one common share and one series B warrant. Each warrant will entitle the holder to purchase one additional common share at $1.50 per share for a period of five years. All fees and expenses incident to the performance of or compliance with, this agreement shall be borne by the company.